How Much Can FDA Approval Increase a Drug Company's Stock Value?

  • Thread starter gravenewworld
  • Start date
In summary, a drug has been approved by the FDA that is the first of its kind. The company's stock is expected to reach $8-10 tomorrow and they have other promising drugs in their pipeline. The drug could potentially bring in billions of dollars as it targets a large market. The drug was initially facing complications for long-term use, but the FDA has lifted its hold and research will continue. The company also has two other promising drugs in phase II that target different opioid receptors.
  • #1
gravenewworld
1,132
26
MY DRUG GOT APPROVED BY THE FDA AND IT IS THE FIRST DRUG OF ITS KIND!

http://biz.yahoo.com/bw/080520/20080520006603.html?.v=1


I've got at least 10,000 shares at $3.00. My stock should reach the $8-10 range tomorrow when the market opens. We've got a ton of other good crap in our pipeline, I could become filthy rich from just working here.
 
Physics news on Phys.org
  • #2
gravenewworld said:
MY DRUG GOT APPROVED BY THE FDA AND IT IS THE FIRST DRUG OF ITS KIND!

http://biz.yahoo.com/bw/080520/20080520006603.html?.v=1


I've got at least 10,000 shares at $3.00. My stock should reach the $8-10 range tomorrow when the market opens. We've got a ton of other good crap in our pipeline, I could become filthy rich from just working here.

Good--great---



--and, I'm glad you're not working on bad crap
 
  • #3
Congrats!
 
  • #4
That's exciting. I'm really happy because I might make 25,000 over the next 4 months...
 
  • #5
Is it really possible for the stock to increase 200% on just this one drug ? I mean is it really something many people are suffering from bowel reconstruction? If it were a cancer drug I would believe it but i guess we'll have to wait and see.
congrats on the windfall
 
  • #6
So, does this mean I should buy a whole bunch?

Are you sure you can announce this?
 
  • #7
Nice. You guys must have a good hunch or something.
 
  • #8
Cyrus said:
So, does this mean I should buy a whole bunch?

Are you sure you can announce this?

its a press announcement
 
  • #9
The press release is already posted, so its ok for him to mention it. By the way, good job!
 
  • #10
Good luck GNW!
 
  • #11
Congrats! Though, I'm a bit confused. I thought that was the drug you were talking about a while ago that was running into major side effects in clinical trials and facing discontinuation. Or was it something similar in name/function, but not this one?
 
  • #12
16%+ in after market, looks like it will be a good day for you tomorrow! Next time tell us the day before the PR... JK! :)
 
Last edited:
  • #13
Greg Bernhardt said:
16%+ in after market, looks like it will be a good day for you tomorrow! Next time tell us the day before the PR... JK! :)

Should we start calling you Martha? :smile:
 
  • #14
gravenewworld said:
I could become filthy rich from just working here.

btw, you should donate some of that to charit... Physics Forums :)
 
  • #15
Congrats gnw. Don't go crazy spending it now. Certainly that could be useful for paying off school loans.

Hopefully this will boost the companies revenues and provide some breathing room for the near term.
 
  • #16
Moonbear said:
Congrats! Though, I'm a bit confused. I thought that was the drug you were talking about a while ago that was running into major side effects in clinical trials and facing discontinuation. Or was it something similar in name/function, but not this one?
Ha, it is the same drug indeed. So far, it is approved for short term use after post operative ileus surgery. The complications we have ran into were for long term usage of the drug to treat opioid bowel disfunction (OBD) which comes from the long term use of opioid analgesics for chronic pain. The FDA put a clinical hold against us for clinical trials in OBD, but after today the FDA lifted its hold and research will continue. This is why I think the stock will nearly double. The OBD market is much bigger and probably worth at least a billion dollars or more. If you look at the data from the last clinical trial for OBD all of the negative incidents came from only 1 research site. Why? Research will continue. Right now we also have a 2 delta opioid agonists in phase II right now. The delta compounds are the first opioid pain killers out there to target the delta receptor. If that shows good data too, the sky is the limit since we have even more good stuff in our pipeline.

http://sec.edgar-online.com/2007/12/05/0001193125-07-259725/Section10.asp FYI---if you are not familiar with opioids, opioids are some of the most potent analgesics known. There are 3 main opioid receptors: mu, kappa, and delta. Drugs like morphine target the mu receptor. Our 2 compounds in phase II target the delta, which no drug out there right now does.
 
Last edited by a moderator:
  • #17
Congratulations! You work in Exton?
 
  • #18
z-component said:
Congratulations! You work in Exton?

Yeah.
 
  • #19
gravenewworld said:
Ha, it is the same drug indeed. So far, it is approved for short term use after post operative ileus surgery. The complications we have ran into were for long term usage of the drug to treat opioid bowel disfunction (OBD) which comes from the long term use of opioid analgesics for chronic pain. The FDA put a clinical hold against us for clinical trials in OBD, but after today the FDA lifted its hold and research will continue. This is why I think the stock will nearly double. The OBD market is much bigger and probably worth at least a billion dollars or more. If you look at the data from the last clinical trial for OBD all of the negative incidents came from only 1 research site. Why? Research will continue.


Right now we also have a 2 delta opioid agonists in phase II right now. The delta compounds are the first opioid pain killers out there to target the delta receptor. If that shows good data too, the sky is the limit since we have even more good stuff in our pipeline.

http://sec.edgar-online.com/2007/12/05/0001193125-07-259725/Section10.asp





FYI---if you are not familiar with opioids, opioids are some of the most potent analgesics known. There are 3 main opioid receptors: mu, kappa, and delta. Drugs like morphine target the mu receptor. Our 2 compounds in phase II target the delta, which no drug out there right now does.
Ah, cool.

If you develop one specific for the kappa receptor, let me know! :biggrin: We're interested in that one in controlling reproductive cycles.
 
Last edited by a moderator:
  • #20
Moonbear said:
Ah, cool.

If you develop one specific for the kappa receptor, let me know! :biggrin: We're interested in that one in controlling reproductive cycles.

Actually you know what? I think we already have explored the kappa receptor. The program was started and axed before I even got there (for reasons I do not know). I'm sure if I look through our compound library I will find some potent kappa agonists/antagonists that we have previously made. The program could have been terminated due to toxicity issues or maybe for the simple fact that we didn't see any in vivo efficacy in pain models. But who knows, maybe they would work in another model for a different treatment.
 
  • #22
Greg Bernhardt said:
Looks like you'll have to wait a bit longer for that big reward gnw! :(

yep...


I had a feeling it wasn't going to be the big growth item like Viagra
 
  • #23
gravenewworld said:
Yeah.
Hey, I live in Collegeville (right near GSK). I'm working on a project in Exton right now - on Lancaster Ave.
 
  • #24
the market is just getting murdered lately. I am aching to get to the sidelines. I'm down 8% today.
 
  • #25
rewebster said:
I had a feeling it wasn't going to be the big growth item like Viagra.
:smile: Sorry, it didn't last more than 4 hours. You did well to get this at $3, it had been as high as $29 at one time.
 
  • #26
Greg Bernhardt said:
Looks like you'll have to wait a bit longer for that big reward gnw! :(

Dang. There is a lot of speculation out there, after FDA approval, why has the stock actually gone down? Many think that the stock is being artifically kept low (which is probably illegal though) so a big firm like GSK can buy us out for much cheaper. Maybe they will give me a 2 year salary severance package, that would be sweet if got that and found a new job right away.
 
  • #27
gravenewworld said:
Dang. There is a lot of speculation out there, after FDA approval, why has the stock actually gone down? Many think that the stock is being artifically kept low (which is probably illegal though) so a big firm like GSK can buy us out for much cheaper. Maybe they will give me a 2 year salary severance package, that would be sweet if got that and found a new job right away.

---you've got another couple drugs in the oven, right?
 
  • #28
rewebster said:
---you've got another couple drugs in the oven, right?

Yeah we have a lot of good stuff going on in R&D right now which I can't discuss and good stuff in the pipeline. That is why a lot of people think we are a huge target for a buy out by a big firm. The company was founded by venture captalists, so if the opportunity comes to make a ton of lucre in a quick manner I'm sure they wouldn't hesitate at all to sell.


Sorry, it didn't last more than 4 hours. You did well to get this at $3, it had been as high as $29 at one time.



Yeah I was here when it was at $29. That was back when our drug had implications for OBD, which is projected to be a billion dollar market. The FDA put us on clinical hold for trials for that indication, but we have a really good shot now at getting that hold lifted.
 
  • #29
gravenewworld said:
Actually you know what? I think we already have explored the kappa receptor. The program was started and axed before I even got there (for reasons I do not know). I'm sure if I look through our compound library I will find some potent kappa agonists/antagonists that we have previously made. The program could have been terminated due to toxicity issues or maybe for the simple fact that we didn't see any in vivo efficacy in pain models. But who knows, maybe they would work in another model for a different treatment.

I'm not interested in them for pain models, so if you find that they aren't toxic and really are specific (and preferably are soluble in aqueous solution), shoot me a PM if there's any chance some could be parted with,and I'll promptly get in touch with my collaborators who really would love a specific kappa antagonist (we can certainly do the whole non-disclosure agreement thing regarding the compound itself, if this is even a possibility).
 
  • #30
Gravenewworld, I think the problem is that this drug was originally intended for the OBD population, which takes meds orally, and this is an oral drug. When that bombed, it was re-targeted to the post-op ileus population. Problem is, it is still an oral drug, and the target population is "NPO" - meaning, they need an IV solution...
 
  • #31
sysreset said:
Gravenewworld, I think the problem is that this drug was originally intended for the OBD population, which takes meds orally, and this is an oral drug. When that bombed, it was re-targeted to the post-op ileus population. Problem is, it is still an oral drug, and the target population is "NPO" - meaning, they need an IV solution...

The drug was originally designed for both POI and OBD at the same time. I don't believe that after bowel surgery patients are restricted ONLY to IV treatment. After bowel surgery, doctors are going to try to get their patients on a solid diet as fast as possible. If a patient can eat solid food, they can take the drug. In the clinical trials for POI, patients were given pills. If the patients really needed an IV formulation, then the drug would have never gotten through for PO use.
 
  • #32
When I saw the OP I thought he must be a high class male prostitute or something. (DC Miestro anyone?)
 
  • #33
binzing said:
When I saw the OP I thought he must be a high class male prostitute or something. (DC Miestro anyone?)

I wish I was, I wish I was... (or is it were?)
 

Related to How Much Can FDA Approval Increase a Drug Company's Stock Value?

1. How is it possible to make $70,000 in just 8 hours?

It is possible to make $70,000 in 8 hours through high-paying jobs such as certain medical professions, engineering, or executive positions. It can also be achieved through successful investments or business ventures.

2. What skills or qualifications are needed to make $70,000 in 8 hours?

The specific skills and qualifications needed to make $70,000 in 8 hours will vary depending on the job or opportunity. Generally, a high level of education, experience, and specialized skills are required to earn such a high income in a short amount of time.

3. Is it common for people to make $70,000 in 8 hours?

No, it is not common for the average person to make $70,000 in 8 hours. This amount of income is considered high and is typically only achievable through certain professions or business ventures.

4. What are the potential risks or challenges associated with making $70,000 in 8 hours?

The potential risks and challenges will depend on the specific job or opportunity. For example, high-paying jobs may come with high levels of stress and responsibility, while investments or business ventures may involve financial risks.

5. Can this level of income be sustained over time?

It is possible for some individuals to sustain a high income of $70,000 in 8 hours over time, but it will depend on their job or opportunities, as well as their ability to maintain their skills and qualifications. It may also require a lot of hard work and dedication to continue earning such a high income consistently.

Hot Threads

Recent Insights

Back
Top